SCHEMBL698231

SCHEMBL698231

C/C(=N\c1c(C)cccc1C)c1cccc(/C(C)=N/c2c(C)cccc2Cl)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 2/20 0.36
GRIN3B O60391 2/20 0.36
GRIN1 Q05586 2/20 0.36
GRIN2A Q12879 2/20 0.36
GRIN2B Q13224 2/20 0.36
GRIN2C Q14957 2/20 0.36
GRIN3A Q8TCU5 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
HSP90AA1 P07900 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ATM Q13315 1/20 0.33
GAA P10253 2/20 0.31
MGAM O43451 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
CYP1A2 P05177 1/20 0.31
DHODH Q02127 1/20 0.31
AGTR1 P30556 1/20 0.31
OPRK1 P41145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL698232 1.00 GRIN2D (0.36) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1164600 0.98 HSP90AA1 (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1164598 0.98 HSP90AA1 (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL20704328 0.97 GRIN2D (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL20704325 0.97 GRIN2D (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL28402825 0.97 GRIN2D (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL28378724 0.97 HSP90AA1 (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL20704327 0.95 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL39684 0.95 HSP90AA1 (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL819180 0.95 HSP90AA1 (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11738334-B2 Supported catalyst systems and processes for use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-08-29 US disclosed
US-11738334-B2 Supported catalyst systems and processes for use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-08-29 US disclosed
US-11718635-B2 Iron bis(imino) aryl catalysts and methods thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-08-08 US disclosed
US-11718635-B2 Iron bis(imino) aryl catalysts and methods thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-08-08 US disclosed
US-20230174757-A1 Linear Low Density Polyethylene for Film Applications EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-06-08 US disclosed
WO-2021222280-A2 LINEAR LOW DENSITY POLYETHYLENE FOR FILM APPLICATIONS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-11-04 WO disclosed
US-20210179650-A1 Iron Bis(Imino) Aryl Catalysts and Methods Thereof EXXONMOBIL CHEMICAL PATENTS INC (US) 2021-06-17 US disclosed
EP-1971577-B1 Process for the preparation of unsymmetric bis(imino) compounds BASELL POLYOLEFINE GMBH (DE) 2014-11-26 EP disclosed
US-8252875-B2 Process for the preparation of unsymmetric bis(imino) compounds BASELL POLYOLEFINE GMBH (DE) 2012-08-28 US disclosed
EP-2423193-A1 Process for preparing imino compounds Basell Polyolefine GmbH (DE) 2012-02-29 EP disclosed
US-7795441-B2 Process for preparing imino compounds BASELL POLYOLEFINE GMBH (DE) 2010-09-14 US disclosed
US-20090054609-A1 Process for the Preparation of Unsymmetric Bis(Imino) Compounds BASELL POLYOLEFINE GMBH (DE) 2009-02-26 US disclosed
US-20090005571-A1 Process for Preparing Imino Compounds BASELL POLYOLEFINE GMBH (DE) 2009-01-01 US disclosed
EP-1973879-A2 PROCESS FOR PREPARING IMINO COMPOUNDS Basell Polyolefine GmbH (DE) 2008-10-01 EP disclosed
WO-2007080121-A2 PROCESS FOR PREPARING IMINO COMPOUNDS BASELL POLYOLEFINE GMBH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210179650-A1 Iron Bis(Imino) Aryl Catalysts and Methods Thereof IDO2, SLC40A1, IDO1 GRIN2D 2591/4885GRIN3B 3166/4885GRIN1 3846/4885
US-20090005571-A1 Process for Preparing Imino Compounds MACO1, C9, PMS2 GRIN2D 2665/4885GRIN3B 2091/4885GRIN1 2466/4885
US-20090054609-A1 Process for the Preparation of Unsymmetric Bis(Imino) Compounds FHIT, OAT, NONO GRIN2D 2981/4885GRIN3B 2131/4885GRIN1 2567/4885
US-11718635-B2 Iron bis(imino) aryl catalysts and methods thereof IDO2, SLC40A1, IDO1 GRIN2D 2591/4885GRIN3B 3166/4885GRIN1 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.